Cargando…
Global reported endophthalmitis risk following intravitreal injections of anti-VEGF: a literature review and analysis
PURPOSE: To report on endophthalmitis occurrence and associated risk factors following the intravitreal injection of anti-VEGF agents based on a review of published literature. MATERIALS AND METHODS: A Medline search was performed using the terms “bevacizumab” and “ranibizumab”. A total of 534 Engli...
Autores principales: | Sigford, Douglas K, Reddy, Shivani, Mollineaux, Christine, Schaal, Shlomit |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4427080/ https://www.ncbi.nlm.nih.gov/pubmed/25999685 http://dx.doi.org/10.2147/OPTH.S77067 |
Ejemplares similares
-
Current Evidence for the Prevention of Endophthalmitis in Anti-VEGF Intravitreal Injections
por: Lau, P. ET., et al.
Publicado: (2018) -
Bacterial endophthalmitis following anti-VEGF intravitreal injections: a retrospective case series
por: Bergamo, Vinicius Campos, et al.
Publicado: (2023) -
Endophthalmitis following intravitreal anti-vascular endothelial growth factor (VEGF) injection: a comprehensive review
por: Merani, Rohan, et al.
Publicado: (2015) -
Incidence of endophthalmitis after intravitreal injection of an anti-VEGF agent with or without topical antibiotics
por: Morioka, Masakazu, et al.
Publicado: (2020) -
Endophthalmitis following intravitreal injection of anti-VEGF agents: long-term outcomes and the identification of unusual micro-organisms
por: Sachdeva, Mira M., et al.
Publicado: (2016)